Garland WA - Search Results

1

Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA. Visentin B, et al. Among authors: garland wa. Cancer Cell. 2006 Mar;9(3):225-38. doi: 10.1016/j.ccr.2006.02.023. Cancer Cell. 2006. PMID: 16530706 Free article.

2

Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.

Caballero S, Swaney J, Moreno K, Afzal A, Kielczewski J, Stoller G, Cavalli A, Garland W, Hansen G, Sabbadini R, Grant MB. Caballero S, et al. Exp Eye Res. 2009 Mar;88(3):367-77. doi: 10.1016/j.exer.2008.07.012. Epub 2008 Aug 6. Exp Eye Res. 2009. PMID: 18723015 Free PMC article.

3

A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization.

Wojnarowicz PM, Lima E Silva R, Ohnaka M, Lee SB, Chin Y, Kulukian A, Chang SH, Desai B, Garcia Escolano M, Shah R, Garcia-Cao M, Xu S, Kadam R, Goldgur Y, Miller MA, Ouerfelli O, Yang G, Arakawa T, Albanese SK, Garland WA, Stoller G, Chaudhary J, Norton L, Soni RK, Philip J, Hendrickson RC, Iavarone A, Dannenberg AJ, Chodera JD, Pavletich N, Lasorella A, Campochiaro PA, Benezra R. Wojnarowicz PM, et al. Among authors: garland wa. Cell Rep. 2019 Oct 1;29(1):62-75.e7. doi: 10.1016/j.celrep.2019.08.073. Cell Rep. 2019. PMID: 31577956 Free PMC article.

4

Anti-tumor effects of an ID antagonist with no observed acquired resistance.

Wojnarowicz PM, Escolano MG, Huang YH, Desai B, Chin Y, Shah R, Xu S, Yadav S, Yaklichkin S, Ouerfelli O, Soni RK, Philip J, Montrose DC, Healey JH, Rajasekhar VK, Garland WA, Ratiu J, Zhuang Y, Norton L, Rosen N, Hendrickson RC, Zhou XK, Iavarone A, Massague J, Dannenberg AJ, Lasorella A, Benezra R. Wojnarowicz PM, et al. Among authors: garland wa. NPJ Breast Cancer. 2021 May 24;7(1):58. doi: 10.1038/s41523-021-00266-0. NPJ Breast Cancer. 2021. PMID: 34031428 Free PMC article.

5

Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia.

Bjugstad KB, Flitter WD, Garland WA, Su GC, Arendash GW. Bjugstad KB, et al. Among authors: garland wa. Brain Res. 1998 Jun 8;795(1-2):349-57. doi: 10.1016/s0006-8993(98)00351-5. Brain Res. 1998. PMID: 9622673

6

CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.

Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. Bjugstad KB, et al. Among authors: garland wa. J Neurovirol. 2000 Dec;6(6):478-91. doi: 10.3109/13550280009091948. J Neurovirol. 2000. PMID: 11175320

7

CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation.

Pulliam L, Irwin I, Kusdra L, Rempel H, Flitter WD, Garland WA. Pulliam L, et al. Among authors: garland wa. Brain Res. 2001 Mar 2;893(1-2):95-103. doi: 10.1016/s0006-8993(00)03293-5. Brain Res. 2001. PMID: 11222997

8

CPI-1189 inhibits interleukin 1beta-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties?

Hensley K, Robinson KA, Pye QN, Floyd RA, Cheng I, Garland WA, Irwin I. Hensley K, et al. Among authors: garland wa. Neurosci Lett. 2000 Mar 10;281(2-3):179-82. doi: 10.1016/s0304-3940(00)00861-2. Neurosci Lett. 2000. PMID: 10704772

9

A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.

Nadeau RW, Satoh H, Scheide S, Crowl R, Conroy R, Garland WA, Liberato DJ. Nadeau RW, et al. Among authors: garland wa. Drug Metab Dispos. 1995 Sep;23(9):904-9. Drug Metab Dispos. 1995. PMID: 8565779

10

A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats.

Meschter CL, Mico BA, Mortillo M, Feldman D, Garland WA, Riley JA, Kaufman LS. Meschter CL, et al. Among authors: garland wa. Fundam Appl Toxicol. 1994 Apr;22(3):369-81. doi: 10.1006/faat.1994.1042. Fundam Appl Toxicol. 1994. PMID: 8050632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page